Comment from WIELICZKO KATHY
AnonymousSupportIndividual
Summary: Kathy Wieliczko, a nurse practitioner, supports the preservation of access to individualized compounded peptide therapies. She argues that restricting these therapies under clinical oversight would not improve safety but would instead push patients toward unregulated sources.
These results happened because I had access to individualized, provider-supervised compounded therapies not available in standard commercial formulations. Restricting that access won’t make patients safer. It removes options that are working, under clinical oversight, and pushes patients toward sourcing these compounds with no oversight at all — the real safety risk.
I ask the Committee to preserve the ability of licensed practitioners and their patients to make individualized treatment decisions using compounded peptide therapies.
Kathy Wieliczko, MSN, APN-C